12:00 AM
Oct 04, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Triple combination therapy: Marketed

Researchers from Amsterdam's National AIDS Therapy Evaluation Center presented 48-week results from the 2-year Atlantic Study, which compares the combination of Bristol-Myers Squibb's Zerit stavudine d4T and Videx didanosine ddI nucleoside...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >